GELS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Gelteq Ltd (GELS.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Gelteq Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

GELS News & Events

Events Timeline

No data

News

7.5

12-09Globenewswire

Gelteq Enters 3-Year Sales Agreement with Mana, Projecting $1.3M Revenue

3.5

12-05Globenewswire

Gelteq's Novel Oral Delivery System Significantly Enhances Bioavailability

3.5

11-24Newsfilter

Gelteq Reports 38-45% Bioavailability Increase in New Antihistamine Gel Formulation

People Also Watch

Frequently Asked Questions

What is Gelteq Ltd (GELS) stock price today?

The current price of GELS is 0.96 USD — it has decreased -4.95 % in the last trading day.

What is Gelteq Ltd (GELS)'s business?

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

What is the price predicton of GELS Stock?

Wall Street analysts forecast GELS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GELS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Gelteq Ltd (GELS)'s revenue for the last quarter?

Gelteq Ltd revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Gelteq Ltd (GELS)'s earnings per share (EPS) for the last quarter?

Gelteq Ltd. EPS for the last quarter amounts to -0.12 USD, increased 20.00 % YoY.

What changes have occurred in the market's expectations for Gelteq Ltd (GELS)'s fundamentals?

The market is revising No Change the revenue expectations for GELS for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -37.25%.

How many employees does Gelteq Ltd (GELS). have?

Gelteq Ltd (GELS) has 7 emplpoyees as of December 16 2025.

What is Gelteq Ltd (GELS) market cap?

Today GELS has the market capitalization of 10.28M USD.